Clinical Physiology of Circulation

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Pathogenesis of blood circulation disorders at sepsis

Authors: B.T. Muzdubaeva

Company:
Kazakh Medical University of Continuing Education, ul. Manasa, 34, Almaty, 050057, Republic of Kazakhstan

E-mail: Сведения доступны для зарегистрированных пользователей.

UDC: 616-005:616.1]616.94

Link: Clinical Physiology of Blood Circulaiton. 2016; 13 (3): 131-138

Quote as: Muzdubaeva B.T. Pathogenesis of blood circulation disorders at sepsis. Klinicheskaya Fiziologiya Krovoobrashcheniya (Clinical Physiology of Circulation, Russian journal). 2016; 13 (3): 131-8 (in Russ.).

Received / Accepted:  25.07.2016 /16.08.2016

Full text:  

Abstract

In the article are performed the main mechanisms and devices of the hemodynamic disorders at sepsis. The heaviness of micro- and macrocirculation with forming the multiorgan failure at sepsis and systemic inflammatory syndrome depends from the combined disorders of the hemodynamic system, hemostasis and immune system. But the leader role in mortality realize the disorders of hemodynamic, that results in the imbalance of the delivery and high demands in oxygen of the organism with development of tissue hypoxia. Sepsis or systemic inflammatory syndrome with infection develop on certain stages and have exact clinical and laboratories criteria. It is allow to diagnose and began early and targeted therapy “at the bed of the patient”. Biological active substances, that responsible for systemic inflammatory syndrome injure first of all the blood circulation system, making it insolvent to compensate disorders at the early stages of inflammation. The pathogenic prescribtion of the certain medicines in exact time, before the septic schok started, help to maintain the blood circulation system in the oxygen delivery, and prevent or not make heavier the multiorgan failure.

References

  1. Dellinger R.P., Levy M.M., Rhodes A. et al. The Surviving Sepsis Campaign (SSC). International Guidelines for Management of Severe Sepsis and Septic Shok: 2012. Crit. Care Med. 2013; 41 (2): 580-633.
  2. Miller R.D., Eriksson L.I., Fleisher L.A., Wiener- Kronish J.P., Young W.L. (ред.). Анестезия: Руководство. Изд. 7-е. СПб: Человек; 2015; 4.[Miller R.D., Eriksson L.I., Fleisher L.A., Wiener-Kronish J.P., Young WL. (eds). Anesthesia. 7th edn. St. Petersburg; 2015 (in Russ.).]
  3. Mccormick B., Gustavo E., Berend M., Aboubdoul F., Pescod D., Wilson I. Update in anesthesia. London: Royal Devon & Exeter NHS Foudation trust; 2014: 255-77.
  4. Parillo J.E. Patogenic mechanisms of septic shock. N. Engl. Med. 1993; 328: 1471-7.
  5. Bhagat K., Hingorani A.D., Palacios M., Charles I.G., Vallance P. Cytokine induced venodilatation in vumans in vivo: eNOS masquerading as iNOS. Cardivasc. Res. 1999; 41: 754-64.
  6. Sharshar T, Gray F., de la Lorin Gradmaison G. et al. Apoptosis of neurons in cardiovascular autonomic centers triggered by inducible nitric oxide synthase after death from septic shock. Lancet. 2003; 3б2: 1799-805.
  7. Чурсин В.В. Физиология кровообращения. Алматы. 2008.[Chursin V.V Physiology of blood circulation. Almaty; 2008 (in Russ.).]
  8. Manu Shankar-Hari, Phillips G.S., Levy M.L. et al. Developing a new defenition and assessing new clinical criteria for septic shock. JAMA. 2016; 315 (8): 775-87. D0I:10.1001/jama.2016.0289.
  9. Vinsonneau C., Gamus C., Combes A. et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multi-organ dysfunction syndrome: A multicenter randomized trial. Lancet. 2006; 368: 379-85.
  10. Schmidt H., Muller-Werdan U., Hoffmann T et al. Autonomic dysfunction predicts mortality in patients with multiple organ disfuction syndrome of different age groups. Crit. Care Med. 2005; 33: 1994-2002.
  11. Sander O., Welters I.D., Foex P, Sear L.W. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with high risk of cardiac complications. Crit. Care Med. 2005; 33: 81-8.
  12. Morelli A., Ertmer C., Westphal M. et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: randomized clinical trial. JAMA. 2013; 310: 1683-91.
  13. Leibovici L., Gafter-Gvili A., Paul M. et al. Relative tachycardia in patients with sepsis: an independent risk factor for mortality. QJM. 2007; 100: 629-34.
  14. Schmittinger C.A., Torgersen C., Luckner G., Schroder D.C., Lorenz I., Dunser M.W Advers cardiac events during cathecholamine vasopressor therapy: a prospective observational study. Intens. Care Med. 2012; 38: 950-8.
  15. Duncer M.W, Hasiberder WR. Sympathetic overstimulation during critical illness: advers effects of adrenergic stress. J. Intens. Care Med. 2009; 24: 293-316.
  16. Magder S.A. The ups and downs of heart rate. Crit. Care Med. 2012; 40: 239-45.
  17. Musialek P, Lei M., Broen H.F., Paterson D.J., Casadei B. Nitric Oxide can oncriease heart rate by stimulating the hyperpolarization - activated inward current, I (f). Circ. Res. 1997; 81: 60-8.
  18. Aoki Y., Hatakkeyama N., Yamamoto S. et al. Role of ion channels in sepsis induced arterial tachyarrhytmias in guinea pigs. Br. J. Pharmacol. 2012; 166: 266-74.
  19. Rudiger A., Singer M. The heart in sepsis. Curr. Vasc. Pharmacol. 2013; 11: 187-95.

 If you found mistakes, select text and press Alt+A